PubMed · 1995 · 14 citations · 9 references
MedicineOphthalmologyPharmacokineticsBiophotonicsOcular Drug DeliveryOcular OncologyBiomedical Laser ApplicationsMelanoma PharmacotherapyOcular PharmacokineticsOcular TumorsPhotodynamic TherapyUveal MelanomaCancer Photodynamic TherapyCharge-coupled Device DetectionExudative Retinal DetachmentIntravascular InjectionLight Penetration DepthThermal DamageTissue Light Penetration DepthTumor Penetration
PURPOSE: To investigate bis (tri-n-hexylsiloxy) silicon 2,3-naphthalocyanine (SINc; 0.5 mg/kg) for photodynamic therapy of an experimental ocular melanoma in pigmented rabbits. METHODS: SINc was dissolved in canola oil by heating, emulsified with Tween 80, and administered by ear vein. Pharmacokinetics were studied in frozen tumor sections by fluorescence microscopy using a charge coupled device, camera-based, low-light detection system with digital image processing at 1 and 24 hours. A Ti:sapphire laser and a microlens were used to deliver the light (770 nm; 40 mW/cm2; 20 J/cm2). A control rabbit received light without SINc. RESULTS: Localization studies of SINc showed intravascular distribution shifting to a tumor stromal and perivascular distribution 24 hours after treatment. Tissue thermal damage after irradiation was minimal in the control. Exudative retinal detachments were not observed. Tumor destruction was observed, with sharp demarcation to a depth of 3.5 mm. CONCLUSIONS: Tumor light penetration was good at 770 nm, and thermal effects from the exciting light alone were minimal. Photodynamic therapy with SINc resulted in localized tumor destruction reflecting the light beam path without damage to adjacent tissue or intraocular complications.
9
Bob L. Wheeler, Ganesan Nagasubramanian, Allen J. Bard et al. · Journal of the American Chemical Society · 1984 · 258 citations
Properties and Applications of Photodynamic Therapy
Charles J. Gomer, Natalie Rucker, Angela Ferrario · Radiation Research · 1989 · 248 citations